Key Record Dates
ClinicalTrials.gov Identifier: | NCT04493099 |
---|---|
Brief Title: | Alvocidib in Combination With Decitabine and Venetoclax in Patients With Relapsed or Refractory AML or as Frontline Therapy in Unfit Patients With AML |
First Submitted : | July 27, 2020 |
First Submitted that Met QC Criteria : | July 27, 2020 |
First Posted : | July 30, 2020 |
Last Update Submitted that Met QC Criteria : | November 9, 2020 |
Last Update Posted : | November 12, 2020 |